US Patent Issued to BIOGEN MA on Jan. 13 for "Bicyclic ether O-glycoprotein-2-acetamido-2-deoxy-3-D-glucopyranosidase inhibitors" (Massachusetts Inventors)

ALEXANDRIA, Va., Jan. 13 -- United States Patent no. 12,522,595, issued on Jan. 13, was assigned to BIOGEN MA INC. (Cambridge, Mass.).

"Bicyclic ether O-glycoprotein-2-acetamido-2-deoxy-3-D-glucopyranosidase inhibitors" was invented by Nathan Genung (Charlestown, Mass.), Kevin M. Guckian (Northborough, Mass.), Jeffrey Vessels (Marlborough, Mass.), Lei Zhang (Westford, Mass.), Ryan Gianatassio (Everett, Mass.), Edward Yin Shiang Lin (Ashland, Mass.) and Zhili Xin (Lexington, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Described herein are compounds represented by formula (I) or a pharmaceutically acceptable salt thereof, pharmaceutical compositions comprising the same and methods of preparing and usi...